In the highly competitive and regulated world of biopharmaceuticals, Biotechnology Contract Manufacturing (CMO) plays a critical role in enabling companies to bring biologic drugs to market efficiently. The choice of a CMO for biologics production is a decision that can significantly impact a company's product development timeline, production costs, and regulatory compliance. Given the complex nature of biologics—such as monoclonal antibodies, gene therapies, and cell-based treatments—pharmaceutical and biotech companies must evaluate several key factors when selecting a CMO. This ensures they partner with a reliable, high-quality manufacturing provider that can meet their specific needs. Key Factors to Consider When Selecting a CMO for Biologics Production Expertise and Experience in Biologics Manufacturing Technical Expertise: Biologics manufacturing requires specialized knowledge, particularly in cell culture, fermentation, purification, and formulation processes. ...